Evaluation of People With Gastrointestinal Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01639924|
Recruitment Status : Recruiting
First Posted : July 13, 2012
Last Update Posted : September 25, 2019
- Gastrointestinal diseases and disorders affect the throat, stomach, and intestines. There are many different kinds of these diseases. Clinical trials are being developed to study new ways to treat them. People who are interested in clinical trials need to be screened before they can take part in the studies. Researchers want to evaluate people with different stomach and intestine disorders to see if they are eligible for clinical trials.
- To study people who have gastrointestinal disorders and see if they are eligible for clinical trials.
- Individuals at least 18 years of age who have or may have a gastrointestinal disorder.
- Participants will be screened with a physical exam and medical history. Blood, urine, and stool samples will be collected. Imaging studies such as x-rays and ultrasound will check to see if the disorder has affected other organs.
- Participants may have tests as needed depending on their disorder. These tests include the following:
- Colonoscopy and endoscopy of the large intestine, esophagus, and stomach.
- Stomach acid analysis to look at stomach pH levels.
- Wireless capsule endoscopy to take pictures of the small intestine.
- Hydrogen breath testing to study issues like bloating, diarrhea, and constipation.
- Sitz Marker Study to see how fast stool moves through the colon.
- Participants may donate extra blood, urine, or stool samples for study. They may also donate stomach contents or tissue from the gut.
- Treatment will not be provided as part of this study. However, participants may be admitted to other clinical trials.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||999999 participants|
|Official Title:||Evaluation of Patients With Gastrointestinal Disease|
|Actual Study Start Date :||July 27, 2012|
Patients with known or suspected gastrointestinal disease
- Patients with gastrointestinal disease [ Time Frame: until protocol closes ]screening protocol for gastrointestinal diseases.
- Allow outpatient evaluation and follow-up of patients with a variety of gastrointestinal diseases for the purposes of physician education in the NIDDK's accredited gastroenterology training program. [ Time Frame: until protocol closes ]evaluation and follow-up of gastrointestinal diseases.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01639924
|Contact: Beverly E Niles||(301) email@example.com|
|Contact: Stephen A Wank, M.D.||(301) firstname.lastname@example.org|
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 email@example.com|
|Principal Investigator:||Stephen A Wank, M.D.||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|